than 1% of newly reported HIV cases were in MSM, and no increase was observed over time [12] .
Only one recent cohort study [13 ] measuring HIV incidence among European MSM could be identified. In Amsterdam, the Netherlands, the annual HIV incidence rate was stable at 1.2% during [1999] [2000] [2001] [2002] [2003] [2004] [2005] . A number of studies reported significant increases in HIV incidence among MSM who underwent repeat testing at sexually transmitted disease (STD) clinics in Rome (from 2.8 to 5.0 per 100 person-years during 1996-2003) [14] and in Valencia (from 1.9 to 3.3 per 100 person-years during [2002] [2003] [15] . In Amsterdam, the HIV incidence among MSM attending STD clinics was estimated to vary from 1.8% in 1998 to 3.8% during 1999-2005, using the Serologic Testing Algorithm for Recent HIV Seroconversion (STARHS) assay [13 ] . In the UK, HIV incidence among MSM attending STD clinics did not change significantly (ranging from 1.5 to 3.3% during 1999-2004, using the STARHS assay) [16] . In recent cross-sectional studies [3 ,17,18] among MSM, the HIV prevalence ranged from 5.3% in Ireland to 18.3% in Spain in Western Europe, from 0% in Lithuania to 2.5% in Slovenia in Central Europe and from 0.0% in Kazakhstan to 6.0% in Moscow in Eastern Europe and the former Soviet Union states.
North America
In 2008, the US Centers for Disease Control and Prevention (CDC) [32] . Papua New Guinea, which has an estimated 1.5% HIV prevalence in the general population, reported 0.1% of the total number of reported HIV infections to be in MSM [11] .
In a community-based cohort study [33] of MSM in Sydney, the HIV incidence density was 0.87 per 100 person-years during 2002-2006 and did not change significantly over time.
In a study [34] (Fig. 1) [36] . Of all infections reported in 2007, 38.5% were in MSM [36] . In 2007 in Singapore, 145 MSM were newly reported with HIV infection, almost four times the 38 cases reported in 2002 (Fig. 1) . MSM accounted for 34.3% of the total number of new HIV cases (423) [37] . In Japan, the number of newly reported HIV cases in MSM more than doubled from 305 in 2002 to 690 in 2007 (Fig. 1) In cross-sectional studies from Southeast Asia, HIV prevalence in MSM ranged from 0.7 to 8.7% in Cambodia [40] , from zero to 7.8% in Vietnam [41, 42] and from 17.3 to 30.8% in Thailand [43, 44] and was 5.6% in Lao PDR [45] . In Myanmar, 29.3% of MSM were found to be HIVinfected in two study sites in 2007 [46] . In mainland China, several recent cross-sectional studies [47] [48] [49] [50] [51] [52] [53] among MSM show HIV prevalence ranging from 0.5% in Jinan to 8.5% in Chongqing and 9.1% in Chengdu (Fig. 2) (Fig. 2) [58] .
In a cross-sectional study [59] among MSM in Chinese Taipei in 2004, the HIV prevalence was 8.5%, in Singapore in 2007, 4.2% [60] and in Hong Kong in 2006-2007, 4.1% [61] . In the Philippines, zero percent prevalence was found among over 500 MSM sampled from Manila and Baguio [62] . In South Asia, recent data from Indonesia show that 2.0, 5.6 and 8.1% of MSM were HIV-infected in cross-sectional studies in Bandung, Surabaya and Jakarta, respectively [63] .
Some information on HIV incidence is available from Thailand, where the HIV incidence density was 5.7 per 100 person-years in a cohort of MSM in Bangkok [64] and 2.7 per 100 person-years among MSM attending an HIV testing clinic using nucleic acid testing to detect acute infection [65 ] . In a study using the STARHS assay among MSM attending STD clinics in Beijing, the estimated HIV incidence was 2.9% in 2005 and 3.6% in 2006 [66] .
In Bangladesh, Pakistan and Nepal, recent biobehavioral surveillance among MSM found 0.2, 2.8 and 3.3%, respectively, to be HIV-infected [11, 67, 68] . Sentinel biobehavioral surveillance in 40 districts in India showed the HIV prevalence to be greater than 5% in 21 and greater than 15% in nine districts [69] . Several cross-sectional and clinic-based studies [70, 71] found HIV prevalence among MSM ranging from 4.8 to 24.7% across sites.
Latin America
For Latin America and the Caribbean, systematic HIV/AIDS case reporting data are not available. With notable exceptions, the countries of Latin America and the Caribbean have very low (<0.5%) or low level (0.5-1.0%) adult HIV prevalence [72] . These epidemics are becoming increasingly recognized as being concentrated predominantly among MSM [8] .
Most HIV prevalence data among MSM in Latin America have come from Peru, Mexico, Argentina, Brazil and Colombia [73] . In Peru, where MSM are included in the national biobehavioral HIV surveillance program, the HIV prevalence ranged from 9.8 to 22.3% between sites, and was highest in Lima [74, 75] . High prevalence has been observed in cross-sectional studies [7 ,76,77] among MSM in Bolivia (21.2%), Ecuador (15.1%), Colombia (19.4%), Brazil (7.0-9.8%) and Paraguay (13%). In Mexico, biobehavioral HIV surveillance among MSM showed HIV prevalence of 25.6% across urban centers [7 ] . The average HIV prevalence among MSM across El Salvador, Guatemala, Honduras, Nicaragua and Panama was 11.7%; the lowest prevalence was observed in Nicaragua (7.6%) and the highest in El Salvador (15.3%) [78 ] . There is a paucity of epidemiologic data on HIV among MSM in the Caribbean, but where
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Figure 2 HIV prevalence among men who have sex with men in China data exist, rates have been high; in Trinidad and Tobago, a 2006 study [7 ] found 20.4% of MSM infected; a recent study [79] in Jamaica found an HIV prevalence of 31.8%.
Using the STARHS assay, HIV incidence in MSM in Central American countries was 5.1 per 100 person-years, lowest in Guatemala, 2.1 and highest in Nicaragua, 14.4 [78 ] . (Fig. 3) [80 ] . At entry into a cohort study [81] (Fig. 3) . In a study [89] among 'receptive' MSM in Khartoum State in Sudan in 2005, the HIV prevalence was 9.3%, whereas in a complementary study (Fig. 3) . HIV surveillance in Egypt found 6.3% of MSM infected in 2006 [90] . During follow-up through 2007 in the Kenya cohort study [81] , the HIV incidence was 8.8 per 100 person-years.
Africa and the Middle East
among 'insertive' MSM in 2007, it was 7.8%
Conclusion
Our review shows that the trend of increasing HIV diagnoses among MSM in the Western world is continuing. In addition, steep increases in diagnoses of new HIV infections among MSM were seen in the developed economies of East Asia. In countries where traditional surveillance systems are available, MSM contributed the largest number of new HIV cases, and in some countries, they contributed the majority. A large number of epidemiologic studies have recently established the presence of populations of MSM throughout Sub-Saharan Africa, as well as high HIV prevalence among them. Similarly, populations of MSM with high and increasing HIV prevalence have been identified in Russia, China and in other parts of Asia. High MSM HIV prevalence rates were also seen throughout Latin America and the Caribbean. Globally, only a handful of HIV incidence studies among MSM could be identified, but where available, showed the spread of HIV among MSM to be continuing. Current HIV prevention efforts have been unable to contain or reduce the spread of HIV infection among MSM. Additional behavioral and biomedical interventions are urgently needed.
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